The Role of the Private Sector in the European Market

Table of Contents

1 EXECUTIVE SUMMARY

2 INTRODUCTION

• 2.1 Models of Healthcare Systems in Europe
  • 2.1.1 Role of Private Medical Insurance
  • 2.1.2 Role of Private Providers
    • 2.1.2.1 Leading Providers
• 2.2 The Funding Conundrum
  • 2.2.1 The Dutch Model
• 2.3 Escalating Costs of Healthcare Services and Technology
• 2.4 Private Medical Insurance Increasing
• 2.5 Role of MedTech/Healthcare Companies in Healthcare Provision

3 THE PRIVATE SECTOR'S ROLE IN KEY EU MARKETS

• 3.1 FRANCE
  • 3.1.1 French Health System and the Private Sector
  • 3.1.2 Private Providers
  • 3.1.3 Private Medical Insurance
  • 3.1.4 Market Dynamics
• 3.2 GERMANY
  • 3.2.1 German Health System & the Private Sector
  • 3.2.2 Private Providers
  • 3.2.3 Private Medical Insurance
  • 3.2.4 Market Dynamics
• 3.3 ITALY
  • 3.3.1 Italian Health System and the Private Sector
  • 3.3.2 Private Providers
  • 3.3.3 Private Medical Insurance
  • 3.3.4 Market Dynamics
• 3.4 SPAIN
  • 3.4.1 Spanish Health System & the Private Sector
  • 3.4.2 Private Providers
  • 3.4.3 Private Medical Insurance
  • 3.4.4 Market Dynamics
• 3.5 UK
  • 3.5.1 UK Health System and the Private Sector
  • 3.5.2 Private Providers
  • 3.5.3 Private Medical Insurance
  • 3.5.4 Market Dynamics
• 3.6 Focus on Major New EU Markets
  • 3.6.1 HUNGARY
    • 3.6.1.1 Hungarian Health System and the Private Sector
    • 3.6.1.2 Private Providers
    • 3.6.1.3 Private Medical Insurance
    • 3.6.1.4 Market Dynamics
  • 3.6.2 POLAND
    • 3.6.2.1 Polish Health System and the Private Sector
    • 3.6.2.2 Private Providers
    • 3.6.2.3 Private Medical Insurance
    • 3.6.2.4 Market Dynamics

4 MEDTECH PURCHASING BY PRIVATE PURCHASERS

• 4.1 Key Decision-Makers
• 4.2 Factors Influencing Purchasing Decisions
• 4.3 Purchasing Mechanisms
• 4.4 Group Purchasing
  • 4.4.1 The German Experience
• 4.5 Sales & Marketing Strategies
• 4.6 Leasing

5 THE US MODEL: LESSONS FOR EUROPE

• 5.1 US Healthcare System
  • 5.1.2 Sources of Healthcare Funding
  • 5.1.3 Private Healthcare Insurance
    • 5.1.3.1 Managed Care
    • 5.1.3.2 Trends in Employer-Sponsored Health Insurance
    • 5.1.3.3 Individual Health Insurance
  • 5.1.4 Universal Access Remains Elusive
• 5.2 The US vs Europe: Impact on MedTech
• 5.3 Learning from the US Model
  • 5.3.1 GPOs: The US Experience
    • 5.3.1.1 GPOs: Lessons for Europe
  • 5.3.2 Managed Care
    • 5.3.2.1 The UK Experience
      • 5.3.2.1.1 The Kaiser Model
      • 5.3.2.1.2 The Evercare Programme
  • 5.3.3 Health Technology Assessment
    • 5.3.3.1 Key Lessons

6 THE PRIVATE SECTOR AND MEDTECH INNOVATION

• 6.1 Attitudes to New Technology
• 6.2 Sources of Information on Innovation
• 6.3 Barriers to Adoption by Private Sector
• 6.4 Approving New Medical Technology
• 6.5 Influence of HTA
• 6.6 Procedures Most Commonly Performed in Private Settings
• 6.7 Uptake of Diagnostic Innovation in Private Sector
  • 6.7.1 Case Studies

7 CONCLUSIONS

• 7.1 Public Policies are Driving Private Healthcare
• 7.2 Sales & Marketing Must Adapt to Purchasing Policies
• 7.3 Private Sector Offers Opportunities for Innovation

GLOSSARY